Your browser doesn't support javascript.
loading
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.
Coleman, Robert L; Duska, Linda R; Ramirez, Pedro T; Heymach, John V; Kamat, Aparna A; Modesitt, Susan C; Schmeler, Kathleen M; Iyer, Revathy B; Garcia, Michael E; Miller, Debbie L; Jackson, Edward F; Ng, Chaan S; Kundra, Vikas; Jaffe, Robert; Sood, Anil K.
Affiliation
  • Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, M D Anderson Cancer Center, Houston, TX 77030, USA. rcoleman@mdanderson.org
Lancet Oncol ; 12(12): 1109-17, 2011 Nov.
Article in En | MEDLINE | ID: mdl-21992853
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Peritoneal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Fallopian Tube Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2011 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Peritoneal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Fallopian Tube Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2011 Document type: Article Affiliation country: